# Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso

> **NCT01697787** · PHASE4 · COMPLETED · sponsor: **Centre Muraz** · enrollment: 150 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Amodiaquine-Artesunate
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT01697787
- **Lead sponsor:** Centre Muraz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697787, "Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01697787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*